Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
株式のランク #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
株価
$4.66
時価総額
$43.92M
変化(1日)
-0.63%
変化(1年)
338.04%
FR
取引 Theranexus Société Anonyme (ALTHX)

カテゴリー

Theranexus Société Anonyme(ALTHX)のP/S比率
July 2026 時点のP/S比率 TTM: 38.28
Theranexus Société Anonyme の最新の財務報告および株価によると、現在のP/S比率(TTM)は 38.28 です。2023 年末時点でのP/S比率は 29.32 でした。
Theranexus Société Anonyme の P/S 比率の履歴(2015 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 38.28 1,672.34%
2024 2.16 -92.63%
2023 29.32 30.81%
2022 22.42 -99.94%
2021 40.48K 15,636.51%
2020 257.27 1,228.70%
2019 19.36 -96.16%
2018 503.88 58.16%
2017 318.60 108.08%
2016 153.11 519.84%
2015 24.70 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
4.26 -88.86%
DK
10.29 -73.13%
US
4.31 -88.75%
US
6.44 -83.17%
BE
16.96 -55.70%
NL